Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
vosaroxin
×
Other hematologic neoplasm
×
Clear all
Filters
3
NCT01191801
2018-08-22
VALOR
Sunesis Pharmaceuticals
Phase 3
Completed
711 enrolled
15 charts